518. Comparable Outcomes of Remdesivir and Sotrovimab among High-risk Patients with Mild to Moderate COVID-19 During the Omicron BA.1 Surge

por Chesdachai, Supavit, Rivera (O'Connor), Christina G, Mara, Kristin, Teaford, Hiliary R, Suarez, Maria Gonzalez, Larsen, Jennifer J, Ganesh, Ravindra, Tulledge-Scheitel, Sidna, Razonable, Raymund R
Publicado 2023